Further assessment by GEPIA database analysis of the prognostic effect of the CBX family mRNA expression in CRC revealed that a high CBX2 expression in patients was significantly associated with a worse disease free survival (DFS), as compared with a low CBX2 expression (P = 0.049; Fig. 6b). This evidence concerns the gene CBX2 and colorectal carcinoma.